CSL - Equity Capital And Reserves


CSL reported $18.66B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Arca Biopharma USD 486.72M 17.72M Mar/2026
aTyr Pharma USD 57.93M 82.05M Mar/2026
Bio Path USD -8.49M 482K Mar/2026
Brainstorm Cell Therapeutics USD -11.01M 1.02M Mar/2026
Cara Therapeutics USD 20.95M 6.92M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Esperion Therapeutics USD -307.93M 5.97M Mar/2026
Immunic USD 151.23M 157.91M Mar/2026
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024